Associated Banc-Corp’s Aimmune Therapeutics AIMT Stock Holding History

Associated Banc-Corp’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-29	Closed	-$1K	–	1046
2020 Q3	$1K	Buy	+29	New	+$618	﹤0.01%	980

Associated Banc-Corp's AIMT Position: Q4 2020 in Review

Associated Banc-Corp sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 29 shares — an estimated $1K sold.

Associated Banc-Corp first reported a position in AIMT in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

Associated Banc-Corp reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
Associated Banc-Corp sold 29 Aimmune Therapeutics shares in Q4 2020, an estimated $1K.
Associated Banc-Corp first reported a position in Aimmune Therapeutics in Q3 2020 and held it in 1 quarter.
Associated Banc-Corp's Aimmune Therapeutics position peaked at $1K in Q3 2020.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Associated Banc-Corp's 13F filing for Q4 2020, filed 11 Feb 2021.